Qualigen Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Braeden Lichti
Qualigen Therapeutics | DEFA14A: Others
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | DEF 14A: Definitive information statements
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 424B4: Prospectus
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | EFFECT: Others
Qualigen Therapeutics | CORRESP: CORRESP
Qualigen Therapeutics | CORRESP: CORRESP
Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Qualigen Therapeutics | 10-Q: Q2 2024 Earnings Report
Qualigen Therapeutics | CORRESP: CORRESP
Qualigen Therapeutics | CORRESP: CORRESP
Qualigen Therapeutics | CORRESP: CORRESP
Qualigen Therapeutics | CORRESP: CORRESP
Qualigen Therapeutics | 3: Initial statement of beneficial ownership of securities-Director LIM ROBERT BRADLEY
Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
No Data
No Data